Member Info for WBAFC

The MyGo Mini is the world's most compact real-time PCR instrument

http://www.mygopcr.com/

The SP does not reflect the real true value of this company.

Once the market realises , this company has so much potential to be huge !

* no positivity in previous RNS

There is no mention of how much shares would be allocated to James Wakefield.

How does that work ? What is James Wakefield incentive to bring the share price up ? What does he get ? Does he have to buy shares in open market ?

I think James Wakefield has a very strong influence on the BOD . So what's his package ?

Now we understand the motive why the BOD were silent and we have had positivity to RNS , its because the BOD wanted to bring the SP down as much as possible for the LTIP.

Anyone invested £5+ have been shafted by the BOD and its going to be a long hold ?

What will it take for investor sentiment to return in this share and it to climb up ?

Let's hope & pray Novacyt BOD start protecting their private investors and buy back shares soon now .

So many investors down more than 70% of their investment. Share price is 85% down in 12 months due to poor quality RNS , silence of information from the CEO/ BOD of information to encourage private investors to invest , not declaring contracts won, not declaring products CE marked, not declaring who they are working with such as TATA MD . Novacyt have not protected share holder value.

https://www.investopedia.com/ask/answers/042015/why-would-company-buyback-its-own-shares.asp

I expect a dynamic positive forward strategy for Novacyt and cash to exceed £120M+ for 2021.

This would essentially be David Allmond first major RNS and he will want to get off to a good start with private & institutional investors. He has stated he wants to increase shareholder value. See below link.

https://www.investegate.co.uk/novacyt-s.a./rns/david-allmond-to-be-ceo--graham-mullis-to-retire/202107290700118330G/

https://www.lse.co.uk/rns/NCYT/david-allmond-to-be-ceo-graham-mullis-to-retire-ls7ei7unnot65lp.html

This RNS is proof that David Allmond wants to increase share holder value and he was carefully selected after extensive research by BOD.

http://novacyt.com/wp-content/uploads/2021/07/Novacyt-David-Allmond-announced-as-CEO-following-decision-by-Graham-Mullis-to-retire.pdf

David Allmond has promised shareholders in Novacyt he will increase share holder value.

I believe he is working very hard to negotiate a resolution with DHSC , win further covid big contracts & formulate a non covid revenue stream in years to come.

https://www.linkedin.com/posts/david-allmond-93254846_david-allmond-announced-as-ceo-following-activity-6826565709452062720-QyoW

Don't be fooled by covid rates declining in UK , that's only because of reduced testing in UK. Its the death rates that need to be looked out.

Novacyt will be be generating huge covid & non covid revenues for years ..... non covid revenues will increase year on

Saintsmith

ShaunP collected data / research from investors and who knows what he was doing with it. He mentioned he had contacts with the BOD , so maybe he was GM side kick

My gut feeling is that David Allmond has been very busy negotiating with DHSC and resolving issues. A big contract on its way from DHSC to replace the ones in dispute . A big contract from US / Germany / Middle East / TATA MD.

Those shorting the share need to close up soon because we are going to get a very good RNS . David Allmond will want to impress as this will be his first major RNS as a CEO and will want to create a good feel good factor .. he needs private investors & institutional investors on board.

No news is going to be very good news.

Shorts are running scared and they should be.

If there were 400,000 covid cases recorded in France and around 200,000 cases in Italy daily , I can bet you its going to be similar in UK the number of cases . This UK government are crafty and are disguising the actual covid figures by reducing PCR tests . I would say the cases of covid recorded are related to how many actual PCR tests are done . I would think the rates of covid are increasing in UK . Just look at the death rates .

400,000 cases of covid in France. Just don't understand why Novacyt have not tapped into France covid market.

https://www.worldometers.info/coronavirus/#countries

We have had no updates or media interviews from Numis or SP Angel for over 7 months now ? What are they actually doing for Novacyt ?

I reckon a leak from insiders will start from Monday , we will get to know if its positive or negative. There are always someone who knows what's going on and will leak information..... the city tend to know what's going on way before PI from stock brokers etc

Anyone think we will have some fantastic surprises on RNS on results ?

1. Big contract win
2. DHSC resolution
3. Merger or Acquisition
4. Release of PCR 10 mins
5. Release of home LFT saliva
6. USA growth up date / contracts
7. TATA MD information
8. Share buy back by company
9. Director bonuses / share options
10. Cash for 2021 exceeding £100M +

*field

Novacyt are not just a one hit wonder with covid tests . It has so many areas of testing in different spectra of microbiology diagnostics . With £100M+ cash and plus more to come from DHSC resolution , this will only arm Novacyt and its BOD for M&A / R&D . This company is going to be mid Cap !

It may take a while , but hold onto these shares as they will be worth £15+ .

Each subdivision ( Microgen , IT-IS , Primerdesign ) of Novacyt are specialists in their own filed and will generate revenue

Rates of covid-19 and deaths escalating in India.

TATA MD will want more Q32 / Q16 and big contract on it way.

https://www.worldometers.info/coronavirus/#countries